A Phase 3 Prospective Multi-Center Single-Arm Open-Label Study to Evaluate VeraCept a Long-Acting Reversible Intrauterine Contraceptive for Contraceptive Efficacy Safety and Tolerability

Brief description of study

A research study for woman of child bearing age or potential and interested in using an intrauterine device (IUD) for birth control for up to 5 years.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
Contraceptive
Age: Between 18 Years - 45 Years
Gender: Female

Updated on 09 Mar 2024. Study ID: 831931

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).